High-throughput chemical screening for antivirulence developmental phenotypes in Trypanosoma brucei

Eukaryotic Cell

Volumn 13, Issue 3, 2014, Pages 412-426

  MacGregor, Paula ^a   Ivens, Alasdair ^a   Shave, Steven ^a   Collie, Iain ^b   Gray, David ^b   Auer, Manfred ^a   Matthews, Keith R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MOLECULAR LIBRARY; PROTOZOAL PROTEIN;

DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HIGH THROUGHPUT SCREENING; METABOLISM; MOLECULAR LIBRARY; PATHOGENICITY; PHARMACOLOGY; PHENOTYPE; TRYPANOSOMA BRUCEI BRUCEI; VIRULENCE;

HIGH-THROUGHPUT SCREENING ASSAYS; PHENOTYPE; PROTOZOAN PROTEINS; RNA, MESSENGER; SMALL MOLECULE LIBRARIES; TRYPANOSOMA BRUCEI BRUCEI; VIRULENCE;

EID: 84894835131     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00335-13     Document Type: Article

References (45)

1. Brun R, Blum J, Chappuis F, Burri C. 2010. Human African trypanosomiasis. Lancet 375:148-159. http://dx.doi.org/10.1016/S0140-6736(09)60829-1.
2. Barrett MP, Boykin DW, Brun R, Tidwell RR. 2007. Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br. J. Pharmacol. 152:1155-1171. http://dx.doi.org/10.1038/sj.bjp. 0707354.
3. Simarro PP, Franco J, Diarra A, Postigo JA, Jannin J. 2012. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology 139:842-846. http://dx.doi.org/10.1017 /S0031182012000169.
4. De Rycker M, O'Neill S, Joshi D, Campbell L, Gray DW, Fairlamb AH. 2012. A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes. PLoS Negl. Trop. Dis. 6:e1932. http://dx.doi.org/10.1371/journal.pntd.0001932.
5. Hesse F, Selzer PM, Muhlstadt K, Duszenko M. 1995. A novel cultivation technique for long-term maintenance of bloodstream form trypanosomes in vitro. Mol. Biochem. Parasitol. 70:157-166. http://dx.doi.org/10. 1016/0166-6851(95)00027-X.
6. Jones DC, Hallyburton I, Stojanovski L, Read KD, Frearson JA, Fairlamb AH. 2010. Identification of a kappa-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis. Biochem. Pharmacol. 80:1478-1486. http://dx.doi.org/10.1016/j.bcp. 2010.07.038.
7. Mackey ZB, Baca AM, Mallari JP, Apsel B, Shelat A, Hansell EJ, Chiang PK, Wolff B, Guy KR, Williams J, McKerrow JH. 2006. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. Chem. Biol. Drug Des. 67:355-363. http://dx.doi.org/10.1111/j.1747-0285.2006.00389.x.
8. Sykes ML, Avery VM. 2009. Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427. Am. J. Trop. Med. Hyg. 81:665-674. http://dx.doi.org/10.4269/ajtmh.2009.09-0015.
9. Sykes ML, Baell JB, Kaiser M, Chatelain E, Moawad SR, Ganame D, Ioset JR, Avery VM. 2012. Identification of compounds with antiproliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. PLoS Negl. Trop. Dis. 6:e1896. http://dx.doi.org/10.1371/journal.pntd.0001896.
10. Vodnala SK, Lundback T, Sjoberg B, Svensson R, Rottenberg ME, Hammarstrom LG. 2013. In vitro and in vivo activities of 2-aminopyrazines and 2-aminopyridines in experimental models of human African trypanosomiasis. Antimicrob. Agents Chemother. 57:1012-1018. http: //dx.doi.org/10.1128/AAC.01870-12.
11. Carey KL, Westwood NJ, Mitchison TJ, Ward GE. 2004. A smallmolecule approach to studying invasive mechanisms of Toxoplasma gondii. Proc. Natl. Acad. Sci. U. S. A. 101:7433-7438. http://dx.doi.org/10. 1073/pnas.0307769101.
12. Hall CI, Reese ML, Weerapana E, Child MA, Bowyer PW, Albrow VE, Haraldsen JD, Phillips MR, Sandoval ED, Ward GE, Cravatt BF, Boothroyd JC, Bogyo M. 2011. Chemical genetic screen identifies Toxoplasma DJ-1 as a regulator of parasite secretion, attachment, and invasion. Proc. Natl. Acad. Sci. U. S. A. 108:10568-10573. http://dx.doi.org/10.1073 /pnas.1105622108.
13. Kamau ET, Srinivasan AR, Brown MJ, Fair MG, Caraher EJ, Boyle JP. 2012. A focused small-molecule screen identifies 14 compounds with distinct effects on Toxoplasma gondii. Antimicrob. Agents Chemother. 56: 5581-5590. http://dx.doi.org/10.1128/AAC.00868-12.
14. Rico E, Rojas F, Mony BM, Szoor B, Macgregor P, Matthews KR. 2013. Bloodstream form pre-adaptation to the tsetse fly in Trypanosoma brucei. Front. Cell. Infect. Microbiol. 3:78. http://dx.doi.org/10.3389/fcimb.2013. 00078.
15. Vickerman K. 1965. Polymorphism and mitochondrial activity in sleeping sickness trypanosomes. Nature 208:762-766. http://dx.doi.org/10. 1038/208762a0.
16. MacGregor P, Matthews KR. 2012. Identification of the regulatory elements controlling the transmission stage-specific gene expression of PAD1 in Trypanosoma brucei. Nucleic Acids Res. 40:7705-7717. http://dx. doi.org/10.1093/nar/gks533.
17. Vassella E, Reuner B, Yutzy B, Boshart M. 1997. Differentiation of African trypanosomes is controlled by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. J. Cell Sci. 110:2661-2671.
18. Laxman S, Riechers A, Sadilek M, Schwede F, Beavo JA. 2006. Hydrolysis products of cAMP analogs cause transformation of Trypanosoma brucei from slender to stumpy-like forms. Proc. Natl. Acad. Sci. U. S. A. 103:19194-19199. http://dx.doi.org/10.1073/pnas.0608971103.
19. Breidbach T, Ngazoa E, Steverding D. 2002. Trypanosoma brucei: in vitro slender-to-stumpy differentiation of culture-adapted, monomorphic bloodstream forms. Exp. Parasitol. 101:223-230. http://dx.doi.org/10. 1016/S0014-4894(02)00133-9.
20. Barquilla A, Saldivia M, Diaz R, Bart JM, Vidal I, Calvo E, Hall MN, Navarro M. 2012. Third target of rapamycin complex negatively regulates development of quiescence in Trypanosoma brucei. Proc. Natl. Acad. Sci. U. S. A. 109:14399-14404. http://dx.doi.org/10.1073/pnas.1210465109.
21. Domenicali Pfister D, Burkard G, Morand S, Renggli CK, Roditi I, Vassella E. 2006. A Mitogen-activated protein kinase controls differentiation of bloodstream forms of Trypanosoma brucei. Eukaryot. Cell 5:1126-1135. http://dx.doi.org/10.1128/EC.00094-06.
22. Vassella E, Kramer R, Turner CM, Wankell M, Modes C, van den Bogaard M, Boshart M. 2001. Deletion of a novel protein kinase with PX and FYVE-related domains increases the rate of differentiation of Trypanosoma brucei. Mol. Microbiol. 41:33-46. http://dx.doi.org/10.1046 /j.1365-2958.2001.02471.x.
23. Dean S, Marchetti R, Kirk K, Matthews KR. 2009. A surface transporter family conveys the trypanosome differentiation signal. Nature 459:213-217. http://dx.doi.org/10.1038/nature07997.
24. Biebinger S, Wirtz LE, Lorenz P, Clayton C. 1997. Vectors for inducible expression of toxic gene products in bloodstream and procyclic Trypanosoma brucei. Mol. Biochem. Parasitol. 85:99-112. http://dx.doi.org/10. 1016/S0166-6851(96)02815-0.
25. Hirumi H, Hirumi K. 1989. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J. Parasitol. 75:985-989. http://dx. doi.org/10.2307/3282883.
26. Mony B, MacGregor P, Ivens A, Cowton A, Wilson J, Horn D, Matthews K. 15 December 2013. Genome wide dissection of the quorum sensing signaling pathiway in Trypanosoma brucei. Nature. http://dx.doi. org/10.1038/nature12864.
27. Doerig C. 2004. Protein kinases as targets for anti-parasitic chemotherapy. Biochim. Biophys. Acta 1697:155-168. http://dx.doi.org/10.1016/j. bbapap.2003.11.021.
28. Naula C, Parsons M, Mottram JC. 2005. Protein kinases as drug targets in trypanosomes and Leishmania. Biochim. Biophys. Acta 1754:151-159. http://dx.doi.org/10.1016/j.bbapap.2005.08.018.
29. Parsons M, Worthey EA, Ward PN, Mottram JC. 2005. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. BMCGenomics 6:127. http://dx.doi.org/10.1186/1471-2164-6-127.
30. Raz B, Iten M, Grether-Buhler Y, Kaminsky R, Brun R. 1997. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro. Acta Trop. 68:139-147. http://dx.doi.org/10.1016/S0001-706X(97)00079-X.
31. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3:Article3. http://dx.doi.org/10.2202/1544-6115.1027.
32. Capewell P, Monk S, Ivens A, MacGregor P, Fenn K, Walrad P, Bringaud F, Smith T, Matthews KR. 2013. Regulation of Trypanosoma brucei total and polysomal mRNA during development within its mammalian host. PLoS One 8:e67069. http://dx.doi.org/10.1371/journal.pone. 0067069.
33. Jensen BC, Sivam D, Kifer CT, Myler PJ, Parsons M. 2009. Widespread variation in transcript abundance within and across developmental stages of Trypanosoma brucei. BMC Genomics 10:482. http://dx.doi.org/10.1186 /1471-2164-10-482.
34. Brecht M, Parsons M. 1998. Changes in polysome profiles accompany trypanosome development. Mol. Biochem. Parasitol. 97:189-198. http: //dx.doi.org/10.1016/S0166-6851(98)00151-0.
35. Kabani S, Fenn K, Ross A, Ivens A, Smith TK, Ghazal P, Matthews K. 2009. Genome-wide expression profiling of in vivo-derived bloodstream parasite stages and dynamic analysis ofmRNAalterations during synchronous differentiation in Trypanosoma brucei. BMC Genomics 10:427. http: //dx.doi.org/10.1186/1471-2164-10-427.
36. Queiroz R, Benz C, Fellenberg K, Hoheisel JD, Clayton C. 2009. Transcriptome analysis of differentiating trypanosomes reveals the existence of multiple post-transcriptional regulons. BMC Genomics 10:495. http://dx.doi.org/10.1186/1471-2164-10-495.
37. Barnwell EM, van Deursen FJ, Jeacock L, Smith KA, Maizels RM, Acosta-Serrano A, Matthews K. 2010. Developmental regulation and extracellular release of a VSG expression-site-associated gene product from Trypanosoma brucei bloodstream forms. J. Cell Sci. 123:3401-3411. http://dx.doi.org/10.1242/jcs.068684.
38. Vassella E, Den Abbeele JV, Butikofer P, Renggli CK, Furger A, Brun R, Roditi I. 2000. A major surface glycoprotein of Trypanosoma brucei is expressed transiently during development and can be regulated posttranscriptionally by glycerol or hypoxia. Genes Dev. 14:615-626. http://dx. doi.org/10.1101/gad.14.5.615.
39. Fragoso CM, Schumann Burkard G, Oberle M, Renggli CK, Hilzinger K, Roditi I. 2009. PSSA-2, a membrane-spanning phosphoprotein of Trypanosoma brucei, is required for efficient maturation of infection. PLoS One 4:e7074. http://dx.doi.org/10.1371/journal.pone.0007074.
40. Bakker BM, Mensonides FI, Teusink B, van Hoek P, Michels PA, Westerhoff HV. 2000. Compartmentation protects trypanosomes from the dangerous design of glycolysis. Proc. Natl. Acad. Sci. U. S. A. 97:2087-2092. http://dx.doi.org/10.1073/pnas.030539197.
41. Guerra-Giraldez C, Quijada L, Clayton CE. 2002. Compartmentation of enzymes in a microbody, the glycosome, is essential in Trypanosoma brucei. J. Cell Sci. 115:2651-2658.
42. Opperdoes FR, Borst P. 1977. Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: the glycosome. FEBS Lett. 80:360-364. http://dx.doi.org/10.1016/0014-5793(77)80476-6.
43. Gunasekera K, Wuthrich D, Braga-Lagache S, Heller M, Ochsenreiter T. 2012. Proteome remodelling during development from blood to insectform Trypanosoma brucei quantified by SILAC and mass spectrometry. BMC Genomics 13:556. http://dx.doi.org/10.1186/1471-2164-13-556.
44. Alsford S, Turner DJ, Obado SO, Sanchez-Flores A, Glover L, Berriman M, Hertz-Fowler C, Horn D. 2011. High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome. Genome Res. 21:915-924. http://dx.doi.org/10.1101/gr.115089.110.
45. MacGregor P, Matthews KR. 2010. New discoveries in the transmission biology of sleeping sickness parasites: applying the basics. J. Mol. Med. 88:865-871. http://dx.doi.org/10.1007/s00109-010-0637-y.